Pharmaceutical
Oxford Cannabinoid Technologies’ Shares Fall A Further 20% As Chairman Stands Down Following Market Rule Breach
THE Chairman of a recently-listed UK pharmaceutically-focused cannabis company has stood down after a breach of market rules.